Xeris Biopharma Holdings, Inc. (XERS)
5.81
-0.23
(-3.81%)
USD |
NASDAQ |
Mar 06, 16:00
5.81
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings SG&A Expense (TTM) : 134.87M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 448.72M |
| Zoetis, Inc. | 2.378B |
| Harrow, Inc. | 109.60M |
| Zymeworks, Inc. | 46.08M |
| Vir Biotechnology, Inc. | 92.07M |